title: Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells.
abstract: Increasing evidence suggests that HIV-1-specific cytotoxic T lymphocytes (CTLs) are a key host immune response to HIV-1 infection. Generation of CTL responses for prevention or therapy of HIV-1 infection has several intrinsic technical barriers such as antigen expression and presentation, the varying HLA restrictions between different individuals, and the potential for viral escape by sequence variation or surface molecule alteration on infected cells. A strategy to circumvent these limitations is the construction of a chimeric T cell receptor containing human CD4 or HIV-1-specific Ig sequences linked to the signaling domain of the T cell receptor zeta chain (universal T cell receptor). CD8+ CTLs transduced with this universal receptor can then bind and lyse infected cells that express surface HIV-1 gp120. We evaluated the ability of universal-receptor-bearing CD8+ cells from a seronegative donor to lyse acutely infected cells and inhibit HIV-1 replication in vitro. The kinetics of lysis and efficiency of inhibition were comparable to that of naturally occurring HIV-1-specific CTL clones isolated from infected individuals. Further study will be required to determine the utility of these cells as a therapeutic strategy in vivo.
authors.affiliation: AIDS Research Center and Infectious Disease Unit, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USA.
authors.forename: O O
authors.initials: OO
authors.lastname: Yang
authors.forename: A C
authors.initials: AC
authors.lastname: Tran
authors.forename: S A
authors.initials: SA
authors.lastname: Kalams
authors.forename: R P
authors.initials: RP
authors.lastname: Johnson
authors.forename: M R
authors.initials: MR
authors.lastname: Roberts
authors.forename: B D
authors.initials: BD
authors.lastname: Walker
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000517:prevention & control; D000595:Amino Acid Sequence; D015704:CD4 Antigens / Q000096:biosynthesis / Q000502:physiology*; D002460:Cell Line; D002478:Cells, Cultured; D000939:Epitopes / Q000032:analysis / Q000737:chemistry; D018023:HIV Seronegativity / Q000276:immunology; D015497:HIV-1 / Q000472:pathogenicity / Q000502:physiology*; D006801:Humans; D008565:Membrane Proteins / Q000096:biosynthesis / Q000502:physiology*; D009000:Monocytes / Q000276:immunology / Q000821:virology*; D009842:Oligopeptides / Q000737:chemistry; D011948:Receptors, Antigen, T-Cell / Q000096:biosynthesis / Q000502:physiology*; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology* / Q000821:virology*; D014162:Transfection; D014771:Virion / Q000502:physiology; D014779:Virus Replication
chemical_list: D015704:CD4 Antigens; D000939:Epitopes; D008565:Membrane Proteins; D009842:Oligopeptides; D011948:Receptors, Antigen, T-Cell; D011993:Recombinant Fusion Proteins; C054979:antigen T cell receptor, zeta chain